FEBRUARY 11, 2O25
Biophytis unveils its outlook strategies for 2025 Biophytis today unveils its strategic outlook for the year 2025. Biophytis has improved its competitive positioning and fundamentals
JANUARY 27, 2025
Biophytis announces its participation to the BIOMED FORUM investor conference Biophytis announces its participation in the Biomed Forum organized by All Invest Securities on February
JANUARY 21, 2025
Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China Biophytis today announces the signing of a co-development agreement with AskHelpU, the
JANUARY 14, 2025
Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101 Biophytis announces that it has entered exclusive negotiations with a leading Chinese pharmaceutical
JANUARY 8, 2025
Biophytis Announces New Cash Contribution and Debt Conversion up to €8.6 million to Finance the Obesity Program Cash contribution of €2.5 million from existing and
JANUARY 6, 2025
Biophytis announces temporary suspension of the listing of its shares and share warrants prior to the completion of a refinancing transaction Biophytis announces today that the